Carter Bankshares (CARE) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Raymond James | Downgraded | Outperform → Market Perform | — | Jul 1, 2026 |
| Hovde Group | Downgraded | Outperform → Market Perform | $30.00 from $28.00 | Jun 3, 2026 |
| Freedom Broker | Downgraded | Buy → Hold | $27.00 from $25.00 | May 15, 2026 |
| Hovde Group | Initiated Coverage | Outperform | $22.00 | Oct 2, 2024 |
| Raymond James | Maintained | Outperform | $21.00 from $20.00 | Aug 29, 2024 |
| Raymond James | Upgraded | Market Perform → Outperform | $17.00 | May 1, 2023 |
| Raymond James | Maintained | Market Perform | — | Apr 6, 2023 |
Frequently asked questions
Is CARE a buy, sell, or hold?
Analysts covering Carter Bankshares currently average a Hold rating: 2 buy, 3 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on CARE?
On Jul 1, 2026, Raymond James downgraded Carter Bankshares to Market Perform.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.